|

Depression Clinical Trials in Atlanta, GA

46 recruiting studies within 50 miles

Phase
Trial Phase Dist.
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.Phase 3<1 mi
Glutamatergic Adaptation to Stress as a Mechanism for Anhedonia and Treatment Response With KetamineEarly 1<1 mi
Leucine in Midlife DepressionPhase 2<1 mi
PCORI Comparative Effectiveness Study-Esketamine (Spravato) vs. Ketamine-Equivalence StudyPhase 3<1 mi
JAK Signaling in DepressionPhase 2<1 mi
Dopaminergic Therapy for Anhedonia - 2Phase 4<1 mi
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric PatientsPhase 3<1 mi
ALTO-207 in Adults With Treatment-resistant Depression (TRD)Phase 2<1 mi
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)Phase 3<1 mi
ALTO-100 in Bipolar Disorder With Depression (BD-D)Phase 2<1 mi
Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)N/A<1 mi
A Randomized Study of Azetukalner Versus Placebo in Major Depressive DisorderPhase 3<1 mi
Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)Phase 2<1 mi
Suicidal Behavior in Patients Diagnosed With Bipolar DisorderN/A<1 mi
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive DisorderPhase 2<1 mi
A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive SymptomsPhase 4<1 mi
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)Phase 3<1 mi
Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive DisorderPhase 3<1 mi
Brain Stimulation and Decision-makingN/A<1 mi
Mechanisms of Behavioral Activation (BA)N/A<1 mi
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant DepressionN/A<1 mi
A Study to Explore the Efficacy of JNJ-89495120 in the Treatment of Major Depressive DisorderPhase 2<1 mi
A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II DisorderPhase 2<1 mi
A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive DisorderPhase 3<1 mi
Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.Phase 2<1 mi
Study to Assess the Safety and Effectiveness of NMRA-335140-501Phase 3<1 mi
Inflammation and Depression in People With HIVPhase 2<1 mi
NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)Phase 3<1 mi
The OBSERVE Protocol—<1 mi
A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)Phase 3<1 mi
A Study to Evaluate the Effectiveness of DT-101 in Patients With DepressionPhase 2<1 mi
"A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder"Phase 3<1 mi
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)Phase 3<1 mi
Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disorder (MND) in Persons With HIVPhase 2<1 mi
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia SymptomsPhase 3<1 mi
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive DisorderPhase 3<1 mi
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)Phase 2<1 mi
E-Mindfulness Approaches for Living After Breast CancerPhase 3<1 mi
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical IllnessesPhase 2<1 mi
A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)Phase 26 mi
A Study of Brenipatide in Adult Participants With Major Depressive DisorderPhase 36 mi
A Study to Evaluate Sleep Electroencephalogram (EEG) Features (Brain Activity While Sleeping) in Participants With Major Depressive Disorder (MDD)—12 mi
A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive DisorderPhase 213 mi
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) InhibitorPhase 417 mi
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive DisorderPhase 322 mi
Study of ALTO-300 in MDDPhase 222 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.